190 related articles for article (PubMed ID: 36760261)
1. Prevalence and associated factors of drug-drug interactions in elderly outpatients in a tertiary care hospital: a cross-sectional study based on three databases.
Liu Y; Wang J; Gong H; Li C; Wu J; Xia T; Li C; Li S; Chen M
Ann Transl Med; 2023 Jan; 11(1):17. PubMed ID: 36760261
[TBL] [Abstract][Full Text] [Related]
2. Determination of potential drug-drug interactions in prescription orders dispensed in a community pharmacy setting using Micromedex
Abbas A; Al-Shaibi S; Sankaralingam S; Awaisu A; Kattezhathu VS; Wongwiwatthananukit S; Owusu YB
Int J Clin Pharm; 2022 Apr; 44(2):348-356. PubMed ID: 34811600
[TBL] [Abstract][Full Text] [Related]
3. Potentially Inappropriate Prescribing and Potential Clinically Significant Drug-Drug Interactions in Older Outpatients: Is There Any Association?
Cvetković Z; Perić A; Dobrić S
Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31277258
[No Abstract] [Full Text] [Related]
4. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.
Ramos GV; Guaraldo L; Japiassú AM; Bozza FA
J Clin Pharm Ther; 2015 Feb; 40(1):63-7. PubMed ID: 25329640
[TBL] [Abstract][Full Text] [Related]
5. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study.
Lin CF; Wang CY; Bai CH
Drugs Aging; 2011 Mar; 28(3):219-25. PubMed ID: 21250763
[TBL] [Abstract][Full Text] [Related]
6. Clinically important potential drug-drug interactions in outpatient settings.
Aparasu R; Baer R; Aparasu A
Res Social Adm Pharm; 2007 Dec; 3(4):426-37. PubMed ID: 18082877
[TBL] [Abstract][Full Text] [Related]
7. Drug-drug interaction potential in men treated with enzalutamide: Mind the gap.
Benoist GE; van Oort IM; Smeenk S; Javad A; Somford DM; Burger DM; Mehra N; van Erp NP
Br J Clin Pharmacol; 2018 Jan; 84(1):122-129. PubMed ID: 28881501
[TBL] [Abstract][Full Text] [Related]
8. Real world co-prescribing contraindicated drugs with fluconazole and itraconazole.
Je NK; Youm S; Chun P
Pharmacoepidemiol Drug Saf; 2023 Jul; 32(7):752-762. PubMed ID: 36812157
[TBL] [Abstract][Full Text] [Related]
9. Real-world prevalence of potential drug-drug interactions involving oral antineoplastic agents: a population-based study.
Kim SH; Suh Y; Ah YM; Jun K; Lee JY
Support Care Cancer; 2020 Aug; 28(8):3617-3626. PubMed ID: 31802250
[TBL] [Abstract][Full Text] [Related]
10. Determination and comparison of potential drug-drug interactions using three different databases in northern cyprus community pharmacies.
Alkhalid ZN; Birand N
Niger J Clin Pract; 2022 Dec; 25(12):2005-2009. PubMed ID: 36537458
[TBL] [Abstract][Full Text] [Related]
11. Retrospective cohort observation on psychotropic drug-drug interaction and identification utility from 3 databases: Drugs.com®, Lexicomp®, and Epocrates®.
Pinkoh R; Rodsiri R; Wainipitapong S
PLoS One; 2023; 18(6):e0287575. PubMed ID: 37347788
[TBL] [Abstract][Full Text] [Related]
12. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
Toivo TM; Mikkola JA; Laine K; Airaksinen M
Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of drug-drug interactions in cancer patients treated at a university hospital in North Cyprus using two interaction databases.
Laban AA; Birand N; Chukwunyere U; Abdi A; Basgut B
Niger J Clin Pract; 2021 Jul; 24(7):1067-1071. PubMed ID: 34290184
[TBL] [Abstract][Full Text] [Related]
14. Potential drug-drug interactions among hospitalized patients in a developing country.
Mousavi S; Ghanbari G
Caspian J Intern Med; 2017; 8(4):282-288. PubMed ID: 29201319
[TBL] [Abstract][Full Text] [Related]
15. Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance.
Tulner LR; Frankfort SV; Gijsen GJ; van Campen JP; Koks CH; Beijnen JH
Drugs Aging; 2008; 25(4):343-55. PubMed ID: 18361544
[TBL] [Abstract][Full Text] [Related]
16. Clinically relevant potential drug-drug interactions among outpatients: A nationwide database study.
Jazbar J; Locatelli I; Horvat N; Kos M
Res Social Adm Pharm; 2018 Jun; 14(6):572-580. PubMed ID: 28716467
[TBL] [Abstract][Full Text] [Related]
17. Drug-drug interactions in pediatric oncology patients.
Balk TE; van der Sijs IH; van Gelder T; Janssen JJB; van der Sluis IM; van Leeuwen RWF; Engels FK
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28205376
[TBL] [Abstract][Full Text] [Related]
18. Potential drug-drug interactions in prescriptions to patients over 45 years of age in primary care, southern Brazil.
Teixeira JJ; Crozatti MT; dos Santos CA; Romano-Lieber NS
PLoS One; 2012; 7(10):e47062. PubMed ID: 23071711
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of comorbidity and polypharmacy in middle-aged and elderly patients].
Su BB; Ma JX; Song W; Yuan J; Dong XY; Wan J
Zhonghua Yi Xue Za Zhi; 2020 Jul; 100(25):1983-1987. PubMed ID: 32629601
[No Abstract] [Full Text] [Related]
20. Incidence of Antiretroviral Drug Interactions During Hospital Course: The Role of a Pharmacist-Led Antiretroviral Stewardship Program.
Bias TE; Venugopalan V; Berkowitz LB; Cha A
J Pharm Technol; 2014 Apr; 30(2):48-53. PubMed ID: 34860871
[No Abstract] [Full Text] [Related]
[Next] [New Search]
